Guy Levy Acquires 500,000 Shares of Parabilis Medicines (NASDAQ:PBLS) Stock
I'm LongbridgeAI, I can summarize articles.Guy Levy, a major shareholder of Parabilis Medicines (NASDAQ:PBLS), purchased 500,000 shares on June 11 at an average price of $20.00 per share, totaling $10 million. This transaction increased his direct holdings by 94.88% to 1,027,000 shares, valued at approximately $20.54 million. The purchase was disclosed via an SEC filing, as required for shareholders owning more than 10% of the company.
Parabilis Medicines, Inc. (NASDAQ:PBLS - Get Free Report) major shareholder Guy Levy purchased 500,000 shares of the business's stock in a transaction that occurred on Thursday, June 11th. The shares were purchased at an average cost of $20.00 per share, with a total value of $10,000,000.00. Following the completion of the acquisition, the insider directly owned 1,027,000 shares of the company's stock, valued at $20,540,000. This represents a 94.88% increase in their ownership of the stock. The transaction was disclosed in a filing with the SEC, which can be accessed through this link. Major shareholders that own more than 10% of a company's stock are required to disclose their transactions with the SEC.
Parabilis Medicines Stock Up 1.4%
Shares of PBLS opened at $29.19 on Tuesday. Parabilis Medicines, Inc. has a twelve month low of $24.51 and a twelve month high of $34.47.
Analysts Set New Price Targets
Separately, Wall Street Zen upgraded Parabilis Medicines to a "hold" rating in a research note on Saturday, June 20th.
Check Out Our Latest Analysis on PBLS
Further Reading
- Five stocks we like better than Parabilis Medicines
- The AI Boom Has a Second Act—And It's Playing Out in Optics
- Gold’s 2026 Rally Has Cracked—Is It Time to Buy the Pullback?
- 5 Tech Stocks to Buy on the July Pullback
- Is OpenAI’s IPO Delay a Warning for AI Investors?
This instant news alert was generated by narrative science technology and financial data from InsiderTrades.com in order to provide readers with the fastest and most accurate reporting. Please send any questions or comments about this story to [email protected].
Insider Buying or Selling at Parabilis Medicines?
Sign-up to receive InsiderTrades.com's daily insider buying and selling report for Parabilis Medicines and related companies.
From Our Partners
![]()
SPCX Warning - and Worst News for Stocks in 50 Years
Goldman Sachs and Morgan Stanley are now predicting what could be the worst news for the U.S. stock market in ...
TradeSmith

The startup growing 23 times faster than Nvidia
An official SEC document contains a name Elon Musk revealed on page 146 - a startup that one analyst believes ...
Brownstone Research
![]()
Ticker Revealed: Pre-IPO Access to "Next Elon Musk" Company
We’ve found The Next Elon Musk… and what we believe to be the next Tesla. It’s already racked up $26 billi...
Banyan Hill Publishing
![]()
Buy this stock today
Marc Chaikin, founder of Chaikin Analytics, is sharing a strategy he calls 'Sell This, Buy That' - a way to mo...
Chaikin Analytics
![]()
Rickards Predicts: Trump to buy tiny $2 stock?
Jim Rickards believes the Trump administration is about to take a direct stake in a $2 stock sitting on the la...
Paradigm Press
![]()
PH: Do THESE 4 things to your bank account now …
In a few short months, the US government could gain unprecedented powers over personal bank accounts - includi...
Weiss Ratings
![]()
The $15 Gold Fund That Pays Up to $1,152/Month
Gold is hitting record highs, but most investors are leaving income on the table. A $15 fund is quietly paying...
Investors Alley
![]()
A drilling crew just broke a record nobody expected
A drilling crew in Beaver County, Utah hit 15,765 feet of solid granite in 16 days - a job the Department of E...
Behind the Markets
